Skip to main content

Table 4 The risk factors for early NAI administration by the clinicians

From: The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

Variable p-value OR (95% CI)
Positive for RIDTs < 0.001 3.586 (1.259–10.219)
  1. RIDTs Rapid influenza diagnostic tests